Year |
Citation |
Score |
2014 |
Figley SA, Liu Y, Karadimas SK, Satkunendrarajah K, Fettes P, Spratt SK, Lee G, Ando D, Surosky R, Giedlin M, Fehlings MG. Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury. Plos One. 9: e96137. PMID 24846143 DOI: 10.1371/Journal.Pone.0096137 |
0.522 |
|
2014 |
Figley SA, Khosravi R, Legasto JM, Tseng YF, Fehlings MG. Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury. Journal of Neurotrauma. 31: 541-52. PMID 24237182 DOI: 10.1089/Neu.2013.3034 |
0.506 |
|
2014 |
Figley SA, Liu Y, Karadimas SK, Satkunendrarajah K, Fettes P, Spratt SK, Lee G, Ando D, Surosky R, Giedlin M, Fehlings MG. AdV-ZFP-VEGF does not improve open-field walking (BBB) scores following SCI. Plos One. DOI: 10.1371/Journal.Pone.0096137.G008 |
0.386 |
|
2013 |
Figley SA, Chen Y, Maeda A, Conroy L, McMullen JD, Silver JI, Stapleton S, Vitkin A, Lindsay P, Burrell K, Zadeh G, Fehlings MG, DaCosta RS. A spinal cord window chamber model for in vivo longitudinal multimodal optical and acoustic imaging in a murine model. Plos One. 8: e58081. PMID 23516432 DOI: 10.1371/Journal.Pone.0058081 |
0.39 |
|
2012 |
Ye H, Buttigieg J, Wan Y, Wang J, Figley S, Fehlings MG. Expression and functional role of BK channels in chronically injured spinal cord white matter. Neurobiology of Disease. 47: 225-36. PMID 22534235 DOI: 10.1016/J.Nbd.2012.04.006 |
0.314 |
|
2009 |
Liu Y, Figley S, Spratt SK, Lee G, Ando D, Surosky R, Fehlings MG. An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury. Neurobiology of Disease. 37: 384-93. PMID 19879362 DOI: 10.1016/J.Nbd.2009.10.018 |
0.501 |
|
Show low-probability matches. |